Yue et al. demonstrated that linc00512 reduced the sensitivity of CRC cells to oxaliplatin via the miR-193a-3p/ERBB4/AKT pathway to regulate the expression of miR-193a-3p and ERBB4 [129]. Here, ERBB4 is linked to colorectal carcinoma.